Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business 
UBS Starts CarTrade Tech With Buy Rating, Sees Strong Earnings Growth and ₹4,000 Target 
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX 
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI 
SK Hynix Stock Soars as AI Memory Demand Outlook Fuels Chip Rally 
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth 
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors 
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO 
SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan 
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 
Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand 
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook 
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside 
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft 
SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing 
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion 
PLEASANTON, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced that, consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on February 9, 2016, to stockholders of record on January 22, 2016.
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women's health clinicians with market-leading products and treatment options to improve the delivery of health care to women. Headquartered in Pleasanton, CA, Cooper has approximately 10,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
COO-D
Kim Duncan Vice President, Investor Relations [email protected] 925-460-3663
